CDNA240517C7500
- 0.91
- 0.000.00%
CareDx Newsroom
CareDx Is Maintained at Buy by Craig-Hallum
CareDx Is Maintained at Buy by Craig-Hallum
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA), Amgen (AMGN) and Orasure Technologies (OSUR)
Express News | CareDx, Inc. : Craig-Hallum Raises Target Price to $22 From $15
Landmark Study Shows CareDx's HeartCare Outperforms Dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes With Fewer Biopsies
HeartCare Results Effectively Stratified Patients at Highest Risk for Acute Cellular Rejection Cardiologists Performed the Fewest Biopsies After Dual Negative HeartCare Results Compared to Single or Dual Positive
Express News | HC Wainwright & Co. Reiterates Neutral on CareDx
Balanced Outlook for CareDx: Strong Performance Amid Rising Competition
Maintaining Hold on CareDx Amid Growth, Valuation, and Uncertainty Concerns
Buy Rating Justified: CareDx's Strong Financial Performance and Market Potential
Raymond James Downgrades CareDx to Market Perform From Outperform
Raymond James Downgrades CareDx to Market Perform From Outperform.
Express News | CareDx Inc : Raymond James Cuts to Market Perform From Outperform
Navigating 5 Analyst Ratings For CareDx
Throughout the last three months, 5 analysts have evaluated CareDx (NASDAQ:CDNA), offering a diverse set of opinions from bullish to bearish.The table below summarizes their recent ratings, showcasing
Express News | Raymond James Downgrades CareDx to Market Perform
CareDx Cut to Market Perform by Raymond James Over Valuation
Express News | Goldman Sachs Maintains Buy on CareDx, Raises Price Target to $14
CareDx Is Maintained at Overweight by Stephens & Co.
CareDx Is Maintained at Overweight by Stephens & Co.
CareDx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 18.42% Stephens & Co. $15 → $18 Maintains Overweight 05/09/2024 -1.32% Craig-Hallum → $15 Reite
Express News | CareDx Inc : Stephens Raises Target Price to $18 From $15
CareDx, Inc (NASDAQ:CDNA) Surges 62% Yet Its Low P/S Is No Reason For Excitement
CareDx, Inc (NASDAQ:CDNA) shareholders have had their patience rewarded with a 62% share price jump in the last month. Looking back a bit further, it's encouraging to see the stock is up 84% in the
Earnings Update: Here's Why Analysts Just Lifted Their CareDx, Inc (NASDAQ:CDNA) Price Target To US$13.80
Sector Update: Health Care Stocks Higher Late Afternoon
Health care stocks rose late Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each increasing 0.3%. The iShares Biotechnology ETF (IBB) added 0.1%. In